Form 4: Organon Executive Reports Stock Vesting and RSU Grant

Juliana Drinane, Interim Head of Mfg & Supply at Organon & Co., reported the vesting of restricted stock units and a new equity grant.

Summary

• Juliana Drinane, Interim Head of Mfg & Supply, exercised and vested restricted stock units (RSUs) on March 31, 2026.
• A total of 16,451 shares were acquired through vesting, with 5,636 shares withheld to cover tax obligations at a price of $5.70 per share.
• The reporting person was granted 125,208 new RSUs, which will vest in three equal annual installments starting March 31, 2027.
• Following these transactions, the reporting person holds 33,235.703 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding executive compensation, which is expected in the normal course of business.

Positives

• The executive maintains a significant equity stake in the company, aligning interests with shareholders.
• The new RSU grant serves as a long-term retention incentive for key management personnel.

Negatives

• The transaction involved the withholding of shares to satisfy tax obligations, which is standard but reduces the net share increase for the executive.

Risks

• Future value of equity compensation is subject to market volatility and the performance of Organon & Co. common stock.

Future Outlook

The newly granted 125,208 RSUs are scheduled to vest in three equal installments on March 31, 2027, 2028, and 2029, contingent upon continued service.

Industry Context

StockSavvy.ai notes that this filing is a routine disclosure of executive compensation and does not signal a change in corporate strategy or financial outlook.

Comparison to Industry Standards

• The use of RSUs as a primary vehicle for executive long-term incentive compensation is standard practice among large-cap pharmaceutical companies like Pfizer, Merck, and Viatris.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

• Vesting of the first tranche of the new RSU grant on March 31, 2027.

Key Dates

Keywords

Organon, OGN, Form 4, Insider Trading, Equity Compensation, Restricted Stock Units, Executive Compensation